PepGen Inc. (PEPG)Healthcare | Biotechnology | Boston, United States | NasdaqGS
1.66 USD
-0.08
(-4.335%) ⇩
(April 21, 2026, 12:09 p.m.
EDT)
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:12 a.m. EDT
Extreme short-term downside protection bets vs. weak fundamentals. Despite a NASDAQ 100M+ market cap and a dollar-value put spread positioning the downside, the stock is trapped between catastrophic R&D burn (-$81M oper cash flow), negative earnings history, and severe legal threats (Pomerantz lawsuit). The high short ratio and negative forecasting model stats confirm a 'value trap' scenario where technical support (short put gamma) is heavy but fundamental reality (heavy losses, trial data mixed results) makes a long-term thesis unproven. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.382793 |
| AutoTheta | 0.383376 |
| AutoETS | 0.383550 |
| AutoARIMA | 0.398283 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 26% |
| H-stat | 50.91 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.013 |
| Excess Kurtosis | -0.72 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 11.533 |
| Market Cap | 114,385,816 |
| Forward P/E | -1.42 |
| Beta | 2.34 |
| Website | https://www.pepgen.com |
As of April 19, 2026, 12:12 a.m. EDT: Options data reveals extreme sentiment divergence. April puts (April 17) are heavily skewed towards In-The-Money (ITM) positions at strikes 2.0 and 5.0, with massive open interest (171k and 15k respectively) compared to negligible call ITM interest. Conversely, May 15 and August 21 calls show significant unhedged OTM open interest, indicating speculative bullish positioning for a rebound toward the $5–$10 analyst targets. However, the overwhelming ITM put blockage in the near term (April) signals a strong speculative defense of the downside, suggesting traders expect a decline or stagnation near current multi-year lows.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.06790125 |
| Address1 | 321 Harrison Avenue |
| Address2 | 8th Floor |
| All Time High | 20.0 |
| All Time Low | 0.88 |
| Ask | 1.66 |
| Ask Size | 8 |
| Average Daily Volume10 Day | 1,408,010 |
| Average Daily Volume3 Month | 1,363,080 |
| Average Volume | 1,363,080 |
| Average Volume10Days | 1,408,010 |
| Beta | 2.342 |
| Bid | 1.25 |
| Bid Size | 2 |
| Book Value | 2.141 |
| City | Boston |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.655 |
| Current Ratio | 11.938 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.7499 |
| Day Low | 1.64 |
| Debt To Equity | 11.533 |
| Display Name | PepGen |
| Earnings Timestamp | 1,772,658,000 |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -92,215,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.129 |
| Enterprise Value | -11,882,545 |
| Eps Current Year | -1.165 |
| Eps Forward | -1.164 |
| Eps Trailing Twelve Months | -2.12 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.5727 |
| Fifty Day Average Change | -2.9177 |
| Fifty Day Average Change Percent | -0.6380694 |
| Fifty Two Week Change Percent | 6.7901254 |
| Fifty Two Week High | 7.8 |
| Fifty Two Week High Change | -6.1450005 |
| Fifty Two Week High Change Percent | -0.7878206 |
| Fifty Two Week Low | 1.01 |
| Fifty Two Week Low Change | 0.645 |
| Fifty Two Week Low Change Percent | 0.6386138 |
| Fifty Two Week Range | 1.01 - 7.8 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,651,843,800,000 |
| Float Shares | 36,971,152 |
| Forward Eps | -1.164 |
| Forward P E | -1.4218212 |
| Free Cashflow | -49,845,500 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 56 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00715 |
| Held Percent Institutions | 0.92627996 |
| Implied Shares Outstanding | 69,115,292 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts. |
| Long Name | PepGen Inc. |
| Market | us_market |
| Market Cap | 114,385,816 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_1677986244 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -89,655,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 119,915,031 |
| Number Of Analyst Opinions | 7 |
| Open | 1.74 |
| Operating Cashflow | -81,635,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 781 797 0979 |
| Previous Close | 1.73 |
| Price Eps Current Year | -1.4206009 |
| Price Hint | 4 |
| Price To Book | 0.7730032 |
| Profit Margins | 0.0 |
| Quick Ratio | 11.739 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.07500005 |
| Regular Market Change Percent | -4.335263 |
| Regular Market Day High | 1.7499 |
| Regular Market Day Low | 1.64 |
| Regular Market Day Range | 1.64 - 1.7499 |
| Regular Market Open | 1.74 |
| Regular Market Previous Close | 1.73 |
| Regular Market Price | 1.655 |
| Regular Market Time | 1,776,787,796 |
| Regular Market Volume | 277,084 |
| Return On Assets | -0.36028 |
| Return On Equity | -0.67393994 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 69,115,292 |
| Shares Percent Shares Out | 0.0498 |
| Shares Short | 3,438,459 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,654,341 |
| Short Name | PepGen Inc. |
| Short Percent Of Float | 0.0641 |
| Short Ratio | 1.71 |
| Source Interval | 15 |
| State | MA |
| Symbol | PEPG |
| Target High Price | 20.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 10.28571 |
| Target Median Price | 10.0 |
| Total Cash | 148,456,000 |
| Total Cash Per Share | 2.148 |
| Total Debt | 17,004,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.12 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.98925 |
| Two Hundred Day Average Change | -2.33425 |
| Two Hundred Day Average Change Percent | -0.58513504 |
| Type Disp | Equity |
| Volume | 277,084 |
| Website | https://www.pepgen.com |
| Zip | 2,118 |